Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I.
暂无分享,去创建一个
Rutger O. Vogel | M. Huynen | R. Rodenburg | H. Venselaar | R. Wanders | J. Smeitink | L. P. Van den Heuvel | S. Houten | P. Willems | L. Nijtmans | J. Kronick | J. Gloerich | M. V. D. van den Brand | J. Nouws | T. Hutchin | Saskia J G Hoefs
[1] M. Danson,et al. Citrate synthase. , 2020, Current topics in cellular regulation.
[2] J. Balk,et al. Human Ind1, an Iron-Sulfur Cluster Assembly Factor for Respiratory Complex I , 2009, Molecular and Cellular Biology.
[3] R. Wanders,et al. Mitochondrial long chain fatty acid beta-oxidation in man and mouse. , 2009, Biochimica et biophysica acta.
[4] E. Mayatepek,et al. Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice , 2009, Journal of Lipid Research.
[5] J. Vockley,et al. Acyl-CoA Dehydrogenases: Dynamic History of Protein Family Evolution , 2009, Journal of Molecular Evolution.
[6] Rutger O. Vogel,et al. Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. , 2009, American journal of human genetics.
[7] U. Dillmann,et al. A novel mitochondrial ATP8 gene mutation in a patient with apical hypertrophic cardiomyopathy and neuropathy , 2007, Journal of Medical Genetics.
[8] J. Smeitink,et al. Electrophoresis techniques to investigate defects in oxidative phosphorylation. , 2008, Methods.
[9] V. Mootha,et al. Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. , 2008, American journal of human genetics.
[10] S. Carr,et al. A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology , 2008, Cell.
[11] O. Gascuel,et al. An improved general amino acid replacement matrix. , 2008, Molecular biology and evolution.
[12] R. Rodenburg,et al. NDUFA2 complex I mutation leads to Leigh disease. , 2008, American journal of human genetics.
[13] R. Rodenburg,et al. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. , 2008, Brain : a journal of neurology.
[14] Ann Saada,et al. C6ORF66 is an assembly factor of mitochondrial complex I. , 2008, American journal of human genetics.
[15] Rodrigo Lopez,et al. Clustal W and Clustal X version 2.0 , 2007, Bioinform..
[16] Rutger O. Vogel,et al. Human mitochondrial complex I assembly: a dynamic and versatile process. , 2007, Biochimica et biophysica acta.
[17] J. Silke,et al. Human CIA30 is involved in the early assembly of mitochondrial complex I and mutations in its gene cause disease , 2007, The EMBO journal.
[18] J. Vockley,et al. A New Genetic Disorder in Mitochondrial Fatty Acid β-Oxidation: ACAD9 Deficiency , 2007 .
[19] R. Rodenburg,et al. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. , 2007, Clinical chemistry.
[20] Rutger O. Vogel,et al. Identification of Mitochondrial Complex I Assembly Intermediates by Tracing Tagged NDUFS3 Demonstrates the Entry Point of Mitochondrial Subunits* , 2007, Journal of Biological Chemistry.
[21] Rutger O. Vogel,et al. Cytosolic signaling protein Ecsit also localizes to mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly. , 2007, Genes & development.
[22] E. Shoubridge,et al. A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. , 2005, The Journal of clinical investigation.
[23] Rutger O. Vogel,et al. Human mitochondrial complex I assembly is mediated by NDUFAF1 , 2005, The FEBS journal.
[24] Jerry Vockley,et al. Human Acyl-CoA Dehydrogenase-9 Plays a Novel Role in the Mitochondrial β-Oxidation of Unsaturated Fatty Acids* , 2005, Journal of Biological Chemistry.
[25] Olivier Gascuel,et al. PHYML Online: A Web Server for Fast Maximum Likelihood-Based Phylogenetic Inference , 2018 .
[26] Gert Vriend,et al. Making optimal use of empirical energy functions: Force‐field parameterization in crystal space , 2004, Proteins.
[27] P. Bénit,et al. AIF deficiency compromises oxidative phosphorylation , 2004, The EMBO journal.
[28] Rutger O. Vogel,et al. Human mitochondrial complex I assembles through the combination of evolutionary conserved modules: a framework to interpret complex I deficiencies. , 2004, Human molecular genetics.
[29] M. Mann,et al. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.
[30] Minghui Zhang,et al. Cloning and functional characterization of ACAD-9, a novel member of human acyl-CoA dehydrogenase family. , 2002, Biochemical and biophysical research communications.
[31] V. Tiranti,et al. A novel mtDNA mutation in the ND5 subunit of complex I in two MELAS patients , 2001, Annals of neurology.
[32] G. Sirugo,et al. Functional and genomic analysis of the human mitochondrial intermediate peptidase, a putative protein partner of frataxin. , 2000, Genomics.
[33] P. Barth,et al. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I , 1999, Annals of neurology.
[34] L. D. Schroeder,et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. , 1999, American journal of human genetics.
[35] D. Kurtz,et al. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. Peters,et al. Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)* , 1998, The Journal of Biological Chemistry.
[37] F. Gabreëls,et al. Clinical heterogeneity in respiratory chain complex III deficiency in childhood , 1997, Journal of the Neurological Sciences.
[38] William,et al. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. , 1995, The Journal of clinical investigation.
[39] R. A. Rollins,et al. MIP1, a new yeast gene homologous to the rat mitochondrial intermediate peptidase gene, is required for oxidative metabolism in Saccharomyces cerevisiae. , 1994, Molecular and cellular biology.
[40] R. Scarpulla,et al. Differential regulation of respiratory chain subunits by a CREB-dependent signal transduction pathway. Role of cyclic AMP in cytochrome c and COXIV gene expression. , 1994, The Journal of biological chemistry.
[41] D. Hale,et al. An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. , 1990, Analytical biochemistry.
[42] N. Manning,et al. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts , 1990, Journal of Inherited Metabolic Disease.
[43] R. Scarpulla,et al. Interaction of nuclear factors with multiple sites in the somatic cytochrome c promoter. Characterization of upstream NRF-1, ATF, and intron Sp1 recognition sequences. , 1989, The Journal of biological chemistry.
[44] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[45] A. Lazarow,et al. A microspectrophotometric method for the determination of cytochrome oxidase. , 1951, The Journal of biological chemistry.
[46] Kai Ye,et al. Multi-RELIEF: a method to recognize specificity determining residues from multiple sequence alignments using a Machine-Learning approach for feature weighting , 2008, Bioinform..
[47] J. Vockley,et al. A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. , 2007, American journal of human genetics.
[48] Massimo Zeviani,et al. Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders. , 2006, Cell metabolism.
[49] N. Pfanner,et al. Assaying protein import into mitochondria. , 2001, Methods in cell biology.
[50] J. Peters,et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). , 1998, The Journal of biological chemistry.